Antimicrobial resistance of Staphylococcus aureus and oral streptococci strains from high-risk endocarditis patients

General Dentistry

Volumn 53, Issue 6, 2005, Pages 410-413

  Groppo, Francisco Carlos ^a   Castro, Flavia Meira ^b   Pacheco, Aline Barros Nobrega Dias ^b   Motta, Rogerio Heladio Lopes ^b   De Mattos Filho, Thales Rocha ^b   Ramacciato, Juliana Cama ^b   Florio, Flavia Martao ^b   Meechan, John Gerard ^c  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b Department of Physiological Sciences ^*  (Brazil)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIINFECTIVE AGENT; AZITHROMYCIN; CEFAZOLIN; CLARITHROMYCIN; CLINDAMYCIN; ERYTHROMYCIN; PENICILLIN G;

AGED; ALPHA HEMOLYTIC STREPTOCOCCUS; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL ENDOCARDITIS; DISEASE PREDISPOSITION; DRUG EFFECT; FEMALE; HUMAN; MALE; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY; RISK FACTOR; SALIVA; SKIN; STAPHYLOCOCCUS AUREUS;

AGED; AMOXICILLIN; AMOXICILLIN-POTASSIUM CLAVULANATE COMBINATION; AMPICILLIN; ANTI-BACTERIAL AGENTS; AZITHROMYCIN; CEFAZOLIN; CLARITHROMYCIN; CLINDAMYCIN; DISEASE SUSCEPTIBILITY; DRUG RESISTANCE, BACTERIAL; ENDOCARDITIS, BACTERIAL; ERYTHROMYCIN; FEMALE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PENICILLIN G; RISK FACTORS; SALIVA; SKIN; STAPHYLOCOCCUS AUREUS; VIRIDANS STREPTOCOCCI;

EID: 29244471590     PISSN: 03636771     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Benn M, Hagelskjaer LH, Tvede M. Infective endocarditis, 1984 through 1993: A clinical and microbiological survey. J Intern Med 1997;242:15-22.
2. Mansur AJ, Grinberg M, Gallucci SD, Bellotti G, Jatene A, Pileggi F. [Infective endocarditis: Analysis of 300 episodes.] Arq Bras Cardiol 1990;54:13-21.
3. Ruiz Junior E, Schirmbeck T, Figueiredo LT. A study of infectious endocarditis in Ribeirao Preto, SP-Brazil. Analysis of cases occurring between 1992 and 1997. Arq Bras Cardiol 2000;74:225-231.
4. Dajani AS, Taubert KA, Wilson W, Bolger AF, Bayer A, Ferrieri P, Gewitz MH, Shulman ST, Nouri S, Newburger JW, Hutto C, Pallasch TJ, Gage TW, Levison ME, Peter G, Zuccaro G Jr. Prevention of bacterial endocarditis. Recommendations by the American Heart Association. Circulation 1997;96:358-366.
5. Moreillon P, Que YA. Infective endocarditis. Lancet 2004;363:139-149.
6. Hogevik H, Olaison L, Andersson R, Lindberg J, Alestig K. Epidemiologic aspects of infective endocarditis in an urban population. A 5-year prospective study. Medicine (Baltimore) 1995;74:324-339.
7. Sandre RM, Shafran SD. Infective endocarditis: Review of 135 cases over 9 years. Clin Infect Dis 1996;22:276-286.
8. McCartney AC. Changing trends in infective endocarditis. J Clin Pathol 1992;45: 945-948.
9. Carmona IT, Diz Dios P, Scully C. An update on the controversies in bacterial endocarditis of oral origin. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2002;93:660-670.
10. Eykyn SJ. The treatment of staphylococcal endocarditis. J Antimicrob Chemother 1987;20 Suppl A:161-171.
11. Petti CA, Fowler VG Jr. Staphylococcus aureus bacteremia and endocarditis. Infect Dis Clin North Am 2002;16:413-435, x-xi.
12. Roman RS, Smith J, Walker M, Byrne S, Ramotar K, Dyck B, Kabani A, Nicolle LE. Rapid geographic spread of a methicillin-resistant Staphylococcus aureus strain. Clin Infect Dis 1997;25:698-705.
13. Farias WV, Sader HS, Lerne IL, Pignatari AC. [Sensitivity pattern of 117 clinical isolates of Staphylococcus aureus from 12 hospitals] [article in Portugese]. Rev Assoc Med Bras 1997;43:199-204.
14. Perl TM, Golub JE. New approaches to reduce Staphylococcus aureus nosocomial infection rates: Treating S. aureus nasal carriage. Ann Pharmacother 1998;32:S7-S16.
15. Herzberg MC, Meyer MW. Effects of oral flora on platelets: Possible consequences in cardiovascular disease. J Periodontol 1996;67:1138-1142.
16. Baquero F. Gram-positive resistance: Challenge for the development of new antibiotics. J Antimicrob Chemother 1997;39 Suppl A:1-6.
17. Martinez F, Martin-Luengo F, Garcia A, Valdes M. Treatment of experimental endocarditis caused by penicillin-resistant Streptococcus sanguis with different doses of teicoplanin. Methods Find Exp Clin Pharmacol 1994;16:247-251.
18. Doern GV, Ferraro MJ, Brueggemann AB, Ruoff KL. Emergence of high rates of antimicrobial resistance among viridans group streptococci in the United States. Antimicrob Agents Chemother 1996;40: 891-894.
19. Levy CS, Kogulan P, Gill VJ, Croxton MB, Kane JG, Lucey DR. Endocarditis caused by penicillin-resistant viridans streptococci: 2 cases and controversies in therapy. Clin Infect Dis 2001;33:577-579.
20. Hall GE, Baddour LM. Apparent failure of endocarditis prophylaxis caused by penicillin-resistant Streptococcus mitis. Am J Med Sci 2002;324:51-53.
21. Koneman EW, Allen SD, Janda WM, Schreckenberger PC, Winn WC. Introduction to diagnostic microbiology, ed. 1. Philadelphia: Lippincott Williams & Wilkins; 1994:187-216.
22. National Committee For Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. Document M100-S12 2002;22:50-69.
23. Hoen B. Platelets and platelet inhibitors in infective endocarditis. Curr Infect Dis Rep 2002;4:299-303.
24. Tak T, Reed KD, Haselby RC, McCauley CS Jr, Shukla SK. An update on the epidemiology, pathogenesis and management of infective endocarditis with emphasis on Staphylococcus aureus. WMJ 2002;101:24-33.
25. Moore PA. Dental therapeutic indications for the newer long-acting macrolide antibiotics. J Am Dent Assoc 1999;130:1341-1343.
26. Kohli V. Infective endocarditis. Indian J Pediatr 2002;69:333-339.
27. Scavizzi MR, Labia R, Petitjean OJ, Elbhar A. Antimicrobial susceptibility test: From bacterial population analysis to therapy. Int J Antimicrob Agents 2002;19: 9-20.
28. Felten A, Grandry B, Lagrange PH, Casin I. Evaluation of three techniques for detection of low-level methicillin-resistant Staphylococcus aureus (MRSA): A disk diffusion method with cefoxitin and moxalactam, the Vitek 2 system, and the MRSA-screen latex agglutination test. J Clin Microbiol 2002;40:2766-2771.
29. Grignon B, Tankovic J, Megraud F, Glupczynski Y, Husson MO, Conroy MC, Emond JP, Loulergue J, Raymond J, Fauchere JL. Validation of diffusion methods for macrolide susceptibility testing of Helicobacter pylori. Microb Drug Resist 2002;8:61-66.
30. Chang SC, Hsieh WC, Liu CY. High prevalence of antibiotic resistance of common pathogenic bacteria in Taiwan. The Antibiotic Resistance Study Group of the Infectious Disease Society of the Republic of China. Diag Microbiol Infect Dis 2000;36:107-112.
31. Sandor GK, Carmichael RP, Vasilakos JS. Revised American Heart Association guidelines for the prevention of bacterial endocarditis: Highlights of specific changes for the dental profession. J Can Dent Assoc 1998;64:114-117.
32. Creighton JM. Dental care for the pediatric cardiac patient. J Can Dent Assoc 1992;58:201-202.
33. Steckelberg JM, Melton LJ 3rd, Ilstrup DM, Rouse MS, Wilson WR. Influence of referral bias on the apparent clinical spectrum of infective endocarditis. Am J Med 1990;88:582-588.
34. Jacobson JJ, Patel B, Asher G, Woolliscroft JO, Schaberg D. Oral staphylococcus in older subjects with rheumatoid arthritis. J Am Geriatr Soc 1997;45:590-593.
35. Alcaide F, Linares J, Pallares R, Carratala J, Benitez MA, Gudiol F, Martin R. In vitro activities of 22 beta-lactam antibiotics against penicillin-resistant and penicillin-susceptible viridans group streptococci isolated from blood. Antimicrob Agents Chemother 1995;39:2243-2247.
36. Teng LJ, Hsueh PR, Chen YC, Ho SW, Luh KT. Antimicrobial susceptibility of viridans group streptococci in Taiwan with an emphasis on the high rates of resistance to penicillin and macrolides in Streptococcus oralis. J Antimicrob Chemother 1998;41: 621-627.
37. Chayakul P, Hortiwakul R, Yipintsoi T, Ingviya N. Viridans streptococci in the oral flora of the patients at risk for infective endocarditis: Species and penicillin susceptibilities. J Med Assoc Thai 2002;85:825-830.
38. Monroe S, Polk R. Antimicrobial use and bacterial resistance. Curr Opin Microbiol 2000;3:496-501.
39. Seymour RA, Whitworth JW. Antibiotic prophylaxis for endocarditis, prosthetic joints, and surgery. Dent Clin North Am 2002;46:635-651.